Glaucos iLinkV Boost Collagen Cross linking — DR BRENDAN CRONIN - LASER EYE SURGEON
We now offer the Glaucos Boost corneal collagen cross linking procedure. Glaucos have put many years of research into this exciting new development in cross linking technology for patients with keratoconus, pellucid marginal degeneration and post LASIK ectasia, with keratoconus patients being a key group who benefit from this procedure. The technique uses oxygen to enhance the collagen cross linking effect in the cornea for a safer procedure, a faster improvement in visual acuity, and better patient outcomes. This procedure helps preserve or improve the patient's vision, supporting long-term visual health.
Introduction to Corneal Health
Maintaining healthy corneas is vital for clear vision and overall eye function. The cornea acts as the eye’s front window, focusing light and shielding the inner eye from harm. When the cornea becomes weakened or thinned, as seen in conditions like keratoconus or post LASIK ectasia, vision can deteriorate and the risk of further complications increases. Corneal collagen cross linking is a minimally invasive procedure designed to reinforce the cornea by strengthening the bonds between collagen molecules. By stabilizing the corneal structure, this cross linking procedure helps preserve vision and prevent the progression of corneal ectasia, offering hope to patients affected by these challenging conditions.
Understanding Collagen Cross Linking
Collagen cross linking is a process that naturally occurs in the cornea, where collagen molecules interconnect to provide strength and stability. In diseases such as keratoconus, this natural cross linking is compromised, leading to a weakened and misshapen cornea. Corneal collagen cross linking procedures are designed to restore and enhance this process. By applying riboflavin (vitamin B2) to the cornea and activating it with UV light, new cross-links are formed between collagen molecules. This treatment halts the progression of corneal ectasia, improves the biomechanical strength of the cornea, and leads to better patient outcomes. The use of riboflavin and UV light in these procedures has revolutionized the management of keratoconus and similar conditions, helping to preserve patients’ vision and quality of life.
The Glaucos iLinkV Boost Procedure
The Glaucos iLinkV Boost procedure represents a significant advancement in corneal collagen cross linking treatments. Specifically developed for patients with keratoconus, pellucid marginal degeneration, and post LASIK ectasia, this innovative procedure uses supplemental oxygen to enhance the cross linking effect. During the treatment, riboflavin is applied to the cornea and activated with UV light, promoting the formation of new collagen cross-links. The addition of oxygen accelerates the process, leading to faster visual recovery and improved patient outcomes. The iLinkV Boost procedure is recognized for its safety, effectiveness, and ability to stabilize the cornea, making it a preferred option for both patients and eye care professionals seeking to manage progressive corneal diseases.
Accelerated Treatment Options
For patients seeking a quicker solution, accelerated corneal cross linking procedures offer an effective alternative to traditional methods. Technologies like the Avedro KXL System utilize higher intensity UV light over a shorter period, achieving the same strengthening effect on the cornea in less time. These accelerated cross linking protocols are particularly beneficial for patients with keratoconus or post LASIK ectasia, providing comparable safety and efficacy with reduced treatment duration. The choice of protocol is tailored to each patient, taking into account factors such as corneal thickness, age, and disease severity. Accelerated cross linking has become a popular option due to its convenience, minimal complications, and positive impact on patient outcomes.
Cross Linking Technology
Advancements in cross linking technology have greatly improved the safety and effectiveness of corneal collagen cross linking procedures. The Dresden protocol, pioneered by Wollensak and colleagues, set the standard by combining corneal epithelium removal with riboflavin application and UV light exposure. Newer approaches, such as the epithelium-on (epi-on) protocol, aim to enhance patient comfort and reduce recovery time by preserving the corneal epithelium. Modern systems like the Avedro KXL System have further refined the process, offering precise control over UV light delivery and treatment parameters. Ongoing research continues to explore innovative riboflavin formulations and advanced UV light sources, all with the goal of enhancing patient outcomes, expanding treatment options, and ensuring the highest standards of safety for those undergoing corneal cross linking.